ServerDomes is partnering with Global Green Generation, a global engineering and construction management organization specializing in high-efficiency, AI-ready data center design and delivery, to ...
Terns Pharmaceuticals, Inc. ( TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia December 8, 2025 4:30 PM EST ...
The One Big Beautiful Bill Act (the “Act”) includes significant amendments to bonus depreciation under Section 168(k). The Act permanently ...
Discusses Warehouse Productivity Initiatives and Digital Strategy Including LinOS Platform December 8, 2025 5:00 PM ...
Lundin Gold Inc. ("Lundin Gold" or the "Company") is pleased to announce its 2026 guidance and three-year outlook for its 100% owned Fruta del Norte ("FDN") gold mine in southeast Ecuador. All amounts ...
Why Do Large B-Cell Lymphoma Patients With High Tumor Mutation Burden Relapse on CAR T-Cell Therapy?
Researchers explored this question at ASH and shared data suggesting genomic instability in tumors with high TMB likely enables them to hide from immune attack.
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Institute of Neuroscience, Howard Hughes Medical Institute, University of Oregon, Eugene, United States ...
Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback